Drug Shortage Report for CADUET
Report ID | 187510 |
Drug Identification Number | 02273314 |
Brand name | CADUET |
Common or Proper name | CADUET |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN AMLODIPINE |
Strength(s) | 80MG 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | C10BX |
ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-05-31 |
Actual start date | 2023-06-06 |
Estimated end date | 2024-07-09 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v32 | 2024-04-16 | French | Compare |
v31 | 2024-04-16 | English | Compare |
v30 | 2024-02-28 | French | Compare |
v29 | 2024-02-28 | English | Compare |
v28 | 2024-01-30 | French | Compare |
v27 | 2024-01-30 | English | Compare |
v26 | 2024-01-10 | French | Compare |
v25 | 2024-01-10 | English | Compare |
v24 | 2023-12-12 | French | Compare |
v23 | 2023-12-12 | English | Compare |
v22 | 2023-10-30 | French | Compare |
v21 | 2023-10-30 | English | Compare |
v20 | 2023-10-11 | French | Compare |
v19 | 2023-10-11 | English | Compare |
v18 | 2023-09-20 | French | Compare |
v17 | 2023-09-20 | English | Compare |
v16 | 2023-08-16 | French | Compare |
v15 | 2023-08-16 | English | Compare |
v14 | 2023-06-27 | French | Compare |
v13 | 2023-06-27 | English | Compare |